Moody Aldrich Partners LLC Sells 10,998 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Moody Aldrich Partners LLC lowered its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 19.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 45,897 shares of the company's stock after selling 10,998 shares during the quarter. Moody Aldrich Partners LLC owned 0.05% of HealthEquity worth $4,404,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Raymond James Trust N.A. lifted its holdings in shares of HealthEquity by 4.8% during the 3rd quarter. Raymond James Trust N.A. now owns 2,905 shares of the company's stock valued at $238,000 after buying an additional 132 shares during the period. UMB Bank n.a. lifted its holdings in HealthEquity by 65.6% in the fourth quarter. UMB Bank n.a. now owns 414 shares of the company's stock valued at $40,000 after acquiring an additional 164 shares during the period. Truist Financial Corp boosted its position in HealthEquity by 7.0% in the second quarter. Truist Financial Corp now owns 2,864 shares of the company's stock worth $247,000 after purchasing an additional 188 shares during the last quarter. Elk River Wealth Management LLC grew its stake in shares of HealthEquity by 0.3% during the 3rd quarter. Elk River Wealth Management LLC now owns 66,181 shares of the company's stock valued at $5,417,000 after purchasing an additional 217 shares during the period. Finally, Nicolet Advisory Services LLC increased its position in shares of HealthEquity by 5.8% during the 3rd quarter. Nicolet Advisory Services LLC now owns 4,218 shares of the company's stock valued at $330,000 after purchasing an additional 233 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company's stock.

Wall Street Analyst Weigh In

HQY has been the topic of a number of research reports. Barrington Research raised their price objective on shares of HealthEquity from $105.00 to $120.00 and gave the stock an "outperform" rating in a report on Monday, December 2nd. JMP Securities lifted their price target on shares of HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a research note on Tuesday, December 10th. Mizuho initiated coverage on HealthEquity in a research note on Wednesday, December 4th. They issued an "outperform" rating and a $126.00 price objective for the company. Royal Bank of Canada lifted their target price on HealthEquity from $100.00 to $105.00 and gave the company an "outperform" rating in a research report on Tuesday, December 10th. Finally, BTIG Research boosted their price target on HealthEquity from $110.00 to $130.00 and gave the company a "buy" rating in a report on Thursday, November 14th. One equities research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat, HealthEquity has an average rating of "Moderate Buy" and a consensus price target of $110.71.

HealthEquity Price Performance

Shares of HealthEquity stock traded down $0.15 on Friday, hitting $110.42. 809,874 shares of the company traded hands, compared to its average volume of 669,662. HealthEquity, Inc. has a 52 week low of $65.01 and a 52 week high of $111.59. The business has a 50-day simple moving average of $100.09 and a 200 day simple moving average of $88.45. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The stock has a market capitalization of $9.57 billion, a P/E ratio of 101.30, a price-to-earnings-growth ratio of 1.91 and a beta of 0.54.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its quarterly earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same quarter in the prior year, the company earned $0.40 earnings per share. Research analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, Director Robert W. Selander sold 8,250 shares of the company's stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $101.56, for a total transaction of $837,870.00. Following the sale, the director now directly owns 66,469 shares in the company, valued at approximately $6,750,591.64. This represents a 11.04 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Stuart B. Parker sold 25,000 shares of HealthEquity stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the transaction, the director now owns 19,061 shares of the company's stock, valued at approximately $1,843,579.92. This represents a 56.74 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 34,289 shares of company stock worth $3,355,718. Corporate insiders own 2.20% of the company's stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.